MILLENNIUM MANAGEMENT LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,142,641
+51.3%
1,069,651
+23.6%
0.02%
+66.7%
Q2 2023$19,256,463
+26839.3%
865,459
-73.8%
0.01%
-78.0%
Q1 2023$71,481
+2187.4%
3,300,152
+2044.8%
0.04%
+1950.0%
Q4 2022$3,125
-99.9%
153,870
+80.5%
0.00%
+100.0%
Q3 2022$2,186,000
-86.6%
85,252
-87.6%
0.00%
-90.0%
Q2 2022$16,320,000
-61.7%
686,309
-63.7%
0.01%
-54.5%
Q1 2022$42,613,000
-53.3%
1,892,241
-59.0%
0.02%
-53.2%
Q4 2021$91,340,000
+3677.5%
4,613,135
+3655.3%
0.05%
+4600.0%
Q3 2021$2,418,000
+0.6%
122,844
+12.5%
0.00%0.0%
Q2 2021$2,403,000
+446.1%
109,226
+491.0%
0.00%
Q1 2021$440,000
-79.9%
18,482
-85.3%
0.00%
-100.0%
Q3 2020$2,191,000
-76.9%
125,895
-77.7%
0.00%
-76.9%
Q2 2020$9,478,000
+126.9%
563,490
+60.4%
0.01%
+44.4%
Q1 2020$4,177,000
-26.3%
351,337
-25.0%
0.01%
+28.6%
Q4 2019$5,671,000
-43.8%
468,699
-34.3%
0.01%
-56.2%
Q3 2019$10,085,000
+357.6%
713,516
+261.0%
0.02%
+433.3%
Q2 2019$2,204,000
-69.8%
197,643
-68.2%
0.00%
-72.7%
Q1 2019$7,305,000
-37.1%
622,273
-28.4%
0.01%
-38.9%
Q4 2018$11,608,000
+223.0%
868,837
+239.0%
0.02%
+350.0%
Q3 2018$3,594,000
+0.3%
256,319
+12.5%
0.00%
-20.0%
Q2 2018$3,583,000
-68.9%
227,904
-67.5%
0.01%
-66.7%
Q1 2018$11,538,000
-50.0%
701,408
-45.1%
0.02%
-51.6%
Q4 2017$23,085,000
+26.3%
1,278,218
+35.0%
0.03%
+10.7%
Q3 2017$18,276,000
+137.5%
946,931
+45.2%
0.03%
+100.0%
Q2 2017$7,696,000
+240.4%
652,162
+216.1%
0.01%
+250.0%
Q1 2017$2,261,000
+109.7%
206,324
+39.0%
0.00%
+100.0%
Q4 2016$1,078,000
-35.4%
148,462
-42.1%
0.00%
-33.3%
Q3 2016$1,668,000
+44.3%
256,555
+21.2%
0.00%0.0%
Q2 2016$1,156,000
+447.9%
211,724
+370.6%
0.00%
+200.0%
Q1 2016$211,000
-81.6%
44,993
-80.5%
0.00%
-50.0%
Q4 2015$1,149,000
-3.6%
230,725
-27.2%
0.00%0.0%
Q3 2015$1,192,000
+62.6%
316,996
+159.9%
0.00%
+100.0%
Q2 2015$733,000
+409.0%
121,986
+373.8%
0.00%
Q1 2015$144,000
-81.8%
25,745
-85.8%
0.00%
-100.0%
Q1 2014$793,000181,8000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders